Immunai AI model for immunology and immuno-oncology trials

Immunai announced a multi-year collaboration with Teva in immunology and immuno-oncology. Immunai says the work will use its AI model, the Immunodynamics Engine, for clinical-trial decisions including mechanism of action, dose selection and biomarker analyses.